Atlas Trials

Osivax

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Osivax

RecordFirmDate
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg (NCT05569239)Osivax2025-09-08
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness (NCT06779981)Osivax2024-12-13
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 (NCT06582277)Osivax2024-10-22
First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers (NCT06128382)Osivax2024-01-08
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. (NCT05734040)Osivax2023-05-10
Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. (NCT05284799)Osivax2022-05-09
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. (NCT05184387)Osivax2021-12-01
Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers. (NCT05060887)Osivax2021-11-15
Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years (NCT04192500)Osivax2019-12-11
Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects (NCT03594890)Osivax2018-06-12

Track Osivax automatically

Every clearance here is in the API, with alerts when new ones post.